2+ hour, 28+ min ago  (807+ words) NEW YORK, June 19, 2026 (GLOBE NEWSWIRE) -- Sleenova draws more attention to the importance of sleep hygiene with its innovative Sound Mask product. About 50 to 70 million American adults have some sleep disorder. That's roughly 1 in 3 who cannot get a good night's sleep,…...

2+ day, 8+ hour ago  (378+ words) Pruitt Health is pleased to announce the addition of four home health offices in South Georgia, reinforcing its commitment to provide high-quality, comprehensive care to patients across the state. This. .. Pruitt Health Expands Home Health Presence in South Georgia NORCROSS,…...

3+ hour, 26+ min ago  (172+ words) Contrast Connect has updated its planning guide for imaging center administrators looking to structure remote contrast coverage staffing under CMS 2026 virtual direct supervision rules. The guide explains how imaging operations can implement CMS's 2026 direct supervision rules by mapping scan volume,…...

3+ hour, 26+ min ago  (273+ words) Dr. Barbara Dominguez and her independently operated chiropractic group have received the 2026 Top Chiropractor distinction from Atlanta Magazine while simultaneously expanding to a tenth clinic in Buford, Georgia, bringing accessible chiropractic care to more communities across the metro area. "This…...

11+ hour, 13+ min ago  (313+ words) Nutraville Expands Product Line with Pineal Guardian X, a Natural Brain Wellness Support markets. businessinsider. com Nutraville Expands Product Line with Pineal Guardian X, a Natural Brain Wellness Support Columbus, OH, June 19, 2026 (GLOBE NEWSWIRE) -- Nutraville, a natural wellness supplement brand,…...

1+ day, 13+ hour ago  (250+ words) Company to present Phase 3-ready pipeline, 12-LOX platform, and pediatric rare-disease expansion to global pharmaceutical partners at the 2026 BIO International Convention in San Diego Kawasaki disease is the leading cause of acquired heart disease in children in developed nations. Patients…...

1+ day, 6+ hour ago  (865+ words) Memento Medicines Launches with $93 Million Series A Financing to advance Tie2 Agonist and VEGF Inhibitor Bispecific Antibody Therapy for Retinal Diseases - Lead program, MMT-205, licensed from Mab Tics Co. , Ltd / Curacle Co. , Ltd. is a potential best-in-class bispecific antibody which activates…...

1+ mon, 10+ hour ago  (525+ words) Late-breaking oral presentation to highlight Allo NK + rituximab clinical responses comparable to autologous CAR T-cell therapy in 31 patients with rheumatologic diseases, including 71% ACR50 response. .. - Late-breaking oral presentation to highlight Allo NK + rituximab clinical responses comparable to autologous CAR T-cell therapy in…...

1+ day, 14+ hour ago  (150+ words) -- First clinical authorization for an in vivo Prime Editing therapy from Prime Medicine -- -- PM577a targets the H1069 Q mutation in the ATP7 B gene, the most prevalent WD-causing allele in North America and Europe -- -- Initiation of Phase 1/2 clinical trial expected in second half…...

3+ day, 15+ hour ago  (557+ words) Invivyd expects to report topline data from LIBERTY in Q3 2026 Data from LIBERTY can provide important insight into the VYD2311 clinical profile by. .. Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus m RNA COVID-19 Vaccine - Invivyd expects to…...